l.dziedzic
TL2 · Mombasa
Contributes reviews on supplier material. Based in Mombasa.
Joined 4 February 2025 · last posted 21h
87 posts, newest first. Showing up to 150.
-
Common supplements people ask about, assessed one at a time Replied, post #106 · Practice › Interactions · 27 Jul 2026 · 0 likes I read post #104 twice before replying, because I had assumed the opposite. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #104 · Nutrition & Training › Protein & intake · 25 Jul 2026 · 2 likes I had written a reply contradicting post #102 and deleted it. Here is what survived. Micronutrient adequacy becomes a real question at very low total intake and is much…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #68 · Practice › Dosing & titration · 25 Jul 2026 · 0 likes Since Micro-titration keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
NHS criteria and how they are applied in practice Replied, post #39 · Regional › UK & Ireland · 23 Jul 2026 · 0 likes NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #38 · Practice › Dosing & titration · 21 Jul 2026 · 0 likes Picking up post #35: that is the part I would want checked first. There is no published evidence about slower escalation because nobody studied it. That means the…
-
Coming back to: Telehealth prescribing models in the US Replied, post #21 · Regional › North America · 19 Jul 2026 · 0 likes This follows post #18 rather than contradicting it. The question underneath Telehealth prescribing models is usually "how would I tell?" rather than "what is true?",…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #86 · Evidence › Journal club · 19 Jul 2026 · 4 likes Coming back to post #84, because the follow-up matters more than the original answer. A request rather than an answer: could whoever has the primary source for SUSTAIN…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #54 · Practice › Interactions · 17 Jul 2026 · 19 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Pages past their review date, listed — does this still hold? Replied, post #50 · Meta › Wiki maintenance · 13 Jul 2026 · 13 likes Outdated external links: if a maintained page links to external sources and those links are broken or pages have moved, reporting that helps keep the page current. That…
-
Here for the analytics and not much else Replied, post #22 · Lounge › Introductions · 12 Jul 2026 · 0 likes Following up: if you introduce yourself and someone asks a follow-up question, you can reply here or in a direct message depending on what feels right. It is the sort…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #17 · Compounds › Repair & healing peptides · 7 Jul 2026 · 15 likes My understanding of absence of controlled human data is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep…
-
Second pass at: Programming during a large energy deficit Replied, post #49 · Nutrition & Training › Resistance training · 28 Jun 2026 · 15 likes Reduced appetite makes fuelling a session harder, and that is a practical problem with practical solutions rather than a reason to stop. The answer changed when I…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #19 · Sourcing › Vendor reports · 27 Jun 2026 · 0 likes I read the earlier replies on Reconciling a supplier certificate twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #80 · Analytics › HPLC & UHPLC · 27 Jun 2026 · 30 likes I would be cautious about generalising from the Carryover example above. It is a good example. It is one example.
-
Follow-up: Search filters: what is missing Replied, post #138 · Meta › Site feedback · 24 Jun 2026 · 23 likes Adding the boring version of Search filters, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations,…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #34 · Start Here › How to Ask · 11 Jun 2026 · 29 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Micronutrient adequacy at low total intake Replied, post #37 · Nutrition & Training › Protein & intake · 9 Jun 2026 · 8 likes Published guidance on protein during weight loss is reasonably consistent and is easy to find, which makes this one of the better-evidenced practical questions here.
-
Pages past their review date, listed — does this still hold? Replied, post #4 · Meta › Wiki maintenance · 6 Jun 2026 · 0 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Injecting into an area that has become firm: why not to Replied, post #10 · Practice › Administration · 3 Jun 2026 · 15 likes Sensible. I would want the same detail before I acted on it either.
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #53 · Pharmacology › Pharmacokinetics · 3 Jun 2026 · 0 likes A missed weekly dose perturbs a slowly moving average rather than creating a trough. That is the pharmacokinetic reason the labelling does not recommend doubling. The…
-
[2026 update] A report I filed that turned out to be wrong, and the correction Replied, post #15 · Sourcing › Vendor reports · 25 May 2026 · 13 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. I looked this up rather than remembered…
-
Blind submission and why it changes minds — the long version Replied, post #91 · Sourcing › Independent verification · 22 May 2026 · 0 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #69 · Compounds › Tirzepatide · 20 May 2026 · 1 like Post #65 and I disagree about the size of the effect, not about the direction. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #67 · Sourcing › Vendor reports · 15 May 2026 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Blind submission and why it changes minds — the long version Replied, post #74 · Sourcing › Independent verification · 14 May 2026 · 15 likes Reading this Blind submission thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #91 · Practice › Interactions · 21 Apr 2026 · 5 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Pancreatitis history and the risk calculus Replied, post #3 · marked as the solution · Safety › Contraindications · 14 Apr 2026 · 7 likes Picking up the opening post: that is the part I would want checked first. I keep a log for pancreatitis history specifically because my memory of it turned out to be…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #24 · Evidence › Preprints · 5 Apr 2026 · 6 likes Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one. One case, stated as…
-
Secretagogues and glucose tolerance: the mechanistic concern — what changed since Replied, post #2 · Compounds › Secretagogues & GH axis · 30 Mar 2026 · 1 like Confirming the opening post from a second method, which matters more than confirming it from a second person. Sermorelin and the growth hormone releasing hormone…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #29 · Research Methods › N-of-1 designs · 3 Mar 2026 · 1 like Worth stating the null on ABAB design before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #56 · Practice › Interactions · 25 Feb 2026 · 0 likes Narrowing post #54, because the general version has more than one answer. Food interactions: most interactions are absorption interactions. Some medications absorb…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #19 · Practice › Dosing & titration · 15 Feb 2026 · 0 likes Picking up post #18: that is the part I would want checked first. Holding at a dose that is working is a legitimate position and it is not what the trial protocols did.…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #79 · Pharmacology › Pharmacokinetics · 9 Feb 2026 · 25 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Journal club: LEADER as the historical anchor Replied, post #29 · Evidence › Journal club · 31 Jan 2026 · 32 likes One caution on LEADER: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #91 · Sourcing › Independent verification · 22 Jan 2026 · 8 likes Confirming post #90 from a second method, which matters more than confirming it from a second person. Worth stating the null on interpreting a result before we explain…
-
What to include when your question involves a chromatogram Replied, post #7 · Start Here › How to Ask · 28 Dec 2025 · 20 likes Post #5 describes the usual case. This is about the unusual one. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #12 · Regional › UK & Ireland · 25 Dec 2025 · 2 likes The most useful contribution is a link to the current official page with the date you accessed it. That survives; a paraphrase does not.
-
Temperature loggers worth the money — the long version Replied, post #97 · Devices › Cold chain · 21 Dec 2025 · 0 likes Post #95 describes the usual case. This is about the unusual one. Recording arrival condition on ordinary deliveries is what makes the record useful. A file containing…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #71 · Compounds › Tirzepatide · 15 Nov 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
Request: a diff view for wiki revisions — the long version Replied, post #66 · Meta › Feature requests · 6 Nov 2025 · 0 likes Coming back to post #65, because the follow-up matters more than the original answer. The number people quote for diff view for wiki revisions is a central estimate…
-
Insurance and replacement policies, compared — the long version Replied, post #28 · Sourcing › Logistics · 18 Oct 2025 · 1 like Post #26 is right about the mechanism and I think understates the practical bit. On Insurance and replacement policies, the part that usually goes wrong is that the…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #7 · Evidence › Trials · 17 Oct 2025 · 0 likes Taking post #4 at face value and following it one step further. I would keep non-inferiority margins and the decision it usually gets used for separate in this thread.…
-
A 40-week log with the measurement method stated Replied, post #14 · Outcomes › Progress reports · 15 Oct 2025 · 1 like Small correction to my own earlier position on 40-week log. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore…
-
Micronutrient adequacy at low total intake — does this still hold? Replied, post #12 · Nutrition & Training › Protein & intake · 6 Oct 2025 · 18 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
-
Follow-up: Why appetite effects are mostly central Replied, post #56 · Pharmacology › Receptor biology · 2 Oct 2025 · 6 likes I would put moderate confidence on the mainstream reading of appetite effects and no more. That is not scepticism for its own sake; it is where the sourcing actually…
-
Cross-border purchase rules within the EU Replied, post #17 · Regional › European Union · 29 Sep 2025 · 0 likes Movement of medicines between member states for personal use has rules, and they are published rather than a matter of custom.
-
Second pass at: Programming during a large energy deficit Replied, post #21 · Nutrition & Training › Resistance training · 28 Sep 2025 · 13 likes That is clearer than the version I had in my head. Thank you.
-
High-resolution MS on aggregates and what it can see Replied, post #75 · Analytics › Mass spectrometry · 23 Sep 2025 · 31 likes My position on high-resolution is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
A preprint whose numbers changed substantially at publication Replied, post #45 · Evidence › Preprints · 8 Sep 2025 · 26 likes Where numbers change between preprint and published version, the changes are not random. They tend toward a smaller effect and a more carefully hedged claim.
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #69 · Compounds › Retatrutide · 29 Aug 2025 · 2 likes The arithmetic in post #67 is right; the assumption feeding it is the part to check. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout…
-
When a preprint is the best available evidence and we say so Replied, post #101 · Evidence › Preprints · 26 Aug 2025 · 17 likes I have been on both sides of the preprint argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #44 · Practice › Dosing & titration · 23 Aug 2025 · 13 likes Taking post #41 at face value and following it one step further. Dose and effect are not linear across the studied range for every compound in this class. Assuming a…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #29 · Evidence › Journal club · 18 Aug 2025 · 14 likes Agreed on all of that, and I have nothing to add to it.
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #18 · Analytics › HPLC & UHPLC · 26 Jul 2025 · 6 likes System suitability is not paperwork. If the replicate injections failed, the run did not happen — the numbers from it are uninterpretable rather than approximate.
-
Critiquing an observational claim about a class effect — one year on Replied, post #2 · Evidence › Study critique · 26 Jul 2025 · 7 likes Criticism is more useful when it is narrower. "The trial answers a different question from the one being asked" is actionable; "the trial is flawed" is not. Not…
-
Managing an unplanned gap in supply — what changed since Replied, post #11 · Access › Shortages · 4 Jul 2025 · 5 likes I had written a reply contradicting post #8 and deleted it. Here is what survived. Where the Managing an unplanned gap discussion usually stalls is that nobody wants to…
-
About the Datasets category Replied, post #9 · Data & Tools › Datasets · 21 Jun 2025 · 31 likes Community-collected datasets: some members have compiled datasets from their own experience and shared them. They are self-reported, unblinded, and therefore limited as…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #15 · Start Here › How to Ask · 20 Jun 2025 · 0 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #64 · Outcomes › Progress reports · 10 Jun 2025 · 12 likes Reframing 18-month record slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is…
-
What a 2 ppm match establishes, and what it does not Replied, post #24 · Analytics › Mass spectrometry · 9 Jun 2025 · 0 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #35 · Pharmacology › Pharmacokinetics · 8 Jun 2025 · 22 likes The documentation on Clearance pathways is better than this thread and I say that as someone who has posted in the thread.
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #103 · Sourcing › Independent verification · 16 May 2025 · 0 likes Building on post #102 rather than restating it. Janoshik is a question about a distribution, not about a value, and treating it as a value is what produces the…
-
Relative retention time as a better inter-laboratory comparator Replied, post #10 · Analytics › Method validation · 16 May 2025 · 0 likes Relative retention time looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Pages past their review date, listed — does this still hold? Replied, post #22 · Meta › Wiki maintenance · 10 May 2025 · 0 likes Answering the question post #20 raises rather than the one it answers. A request rather than an answer: could whoever has the primary source for Pages past post it? I…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #25 · Evidence › Trials · 7 May 2025 · 0 likes Adding a null result on Comparators chosen for regulatory reasons. I looked, carefully, and found nothing, and null results deserve posting precisely because they never…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #32 · Evidence › Journal club · 1 May 2025 · 18 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. I would…
-
Reading a trial's population section before its results — does this still hold? Replied, post #35 · Evidence › Trials · 24 Apr 2025 · 11 likes That is the distinction I keep failing to hold on to. Written down now.
-
Scheduled maintenance and what will be unavailable Replied, post #115 · Meta › Announcements · 19 Apr 2025 · 0 likes Where I part company with post #113, and it is a narrow parting. A methods point on scheduled maintenance rather than a substantive one: if the comparison is not like…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #44 · Practice › Interactions · 11 Apr 2025 · 11 likes Timing separation is the standard mitigation where absorption rate is the concern, and the interval that matters depends on the other drug rather than on this one.
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #118 · Sourcing › Regulatory · 1 Apr 2025 · 3 likes A label change is a regulatory event with a date and a document. Citing the document is what makes a claim about labelling checkable.
-
Talking to a therapist about this specifically — does this still hold? Replied, post #37 · Wellbeing › Mental health · 30 Mar 2025 · 5 likes Expectations set by other people's reported trajectories are a documented source of distress, and the trajectories posted are not representative.
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #119 · Analytics › COA interpretation · 24 Mar 2025 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #4 · Clinical › Comorbidities · 13 Mar 2025 · 0 likes The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about.
-
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #5 · Compounds › Repair & healing peptides · 13 Mar 2025 · 0 likes The arithmetic in post #3 is right; the assumption feeding it is the part to check. The lyophilised cake is worth looking at before adding diluent. A collapsed or…
-
Consistent declarations and why they matter more than clever ones Replied, post #94 · Sourcing › Logistics · 27 Feb 2025 · 7 likes I would rather this thread reach "we do not know" about consistent declarations than reach a confident answer that nobody can support when asked.
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #57 · Devices › Cold chain · 24 Feb 2025 · 0 likes Worth separating Domestic fridge temperature mapping as a question about the compound from Domestic fridge temperature mapping as a question about the documentation.…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #83 · Evidence › Journal club · 6 Jan 2025 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #19 · Safety › Adverse events · 20 Dec 2024 · 2 likes Reporting here and reporting to a national scheme are not alternatives. The second is what feeds safety surveillance. If anyone has run this properly I would rather…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #17 · Compounds › Oral incretins · 18 Dec 2024 · 3 likes The arithmetic in post #14 is right; the assumption feeding it is the part to check. Missed doses behave differently for a daily oral than for a weekly injection. With…
-
Request: a diff view for wiki revisions Replied, post #22 · Meta › Feature requests · 7 Nov 2024 · 9 likes Request: an export of my own posts. Not for any dramatic reason — I want to search my own history offline, and site search is optimised for finding other people's…
-
Sample size in a voluntary survey: the selection problem Replied, post #2 · Data & Tools › Datasets · 31 Oct 2024 · 11 likes That reframing is the whole thing. The facts I already had.
-
Requesting a page: what makes a good request — what changed since Replied, post #75 · Documentation › Wiki requests · 11 Oct 2024 · 0 likes Where I part company with post #71, and it is a narrow parting. A calculator request and a document request are different things, and a calculator without a document…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #74 · Practice › Administration · 2 Oct 2024 · 3 likes Where I part company with post #70, and it is a narrow parting. I would rather this thread reach "we do not know" about site rotation scheme than reach a confident…
-
Priming a pen and whether the primed volume is wasted — one year on Replied, post #6 · Devices › Pens & autoinjectors · 21 Sep 2024 · 0 likes Post #2 and I disagree about the size of the effect, not about the direction. A pen delivers a fixed or dialled dose from a cartridge and is a metering device rather…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #32 · Nutrition & Training › Hydration & electrolytes · 9 Aug 2024 · 0 likes I read post #30 twice before replying, because I had assumed the opposite. Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #56 · Evidence › Journal club · 23 Jul 2024 · 27 likes Adding the measurement that post #53 says would settle it. The baseline characteristics table is the single most useful page for the questions that get asked here,…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #58 · Practice › Dosing & titration · 8 Jul 2024 · 19 likes Taking post #57 at face value and following it one step further. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological…